Sodium taurocholate cotransporting polypeptide in HBV-related diseases: from underlying mechanisms to targeted therapies.

Xie Q, Liu Q, Zheng X, Fu L, Aly HH, Liu B

Open source

DOI
10.1016/j.drudis.2026.104664
Published
2026 May
Container
Drug discovery today
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drudis.2026.104664,
  title = {Sodium taurocholate cotransporting polypeptide in HBV-related diseases: from underlying mechanisms to targeted therapies.},
  author = {Xie Q and Liu Q and Zheng X and Fu L and Aly HH and Liu B},
  year = {2026},
  journal = {Drug discovery today},
  doi = {10.1016/j.drudis.2026.104664},
  url = {https://doi.org/10.1016/j.drudis.2026.104664}
}

RIS

TY  - JOUR
TI  - Sodium taurocholate cotransporting polypeptide in HBV-related diseases: from underlying mechanisms to targeted therapies.
AU  - Xie Q
AU  - Liu Q
AU  - Zheng X
AU  - Fu L
AU  - Aly HH
AU  - Liu B
PY  - 2026
JO  - Drug discovery today
DO  - 10.1016/j.drudis.2026.104664
UR  - https://doi.org/10.1016/j.drudis.2026.104664
ER  - 

APA

Q, X., Q, L., X, Z., L, F., HH, A., & B, L. (2026). Sodium taurocholate cotransporting polypeptide in HBV-related diseases: from underlying mechanisms to targeted therapies.. Drug discovery today. https://doi.org/10.1016/j.drudis.2026.104664

Source records